Cryo-Cell International (CCEL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Cryo-Cell International (CCEL) is Neutral.

The composite score behind that read is -0.21, weighing +0.44 of bullish evidence against -0.33 bearish.

Cryo-Cell International last closed at $3.71, -7.02% on the session.

Against the IVW growth benchmark the position is -7.94% over the forecast window.

The read is built from 12 underlying insights — 2 bullish and 10 bearish.

Agreement across those insights is 83%.

16 graded predictions for CCEL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Cryo-Cell International in the 71st percentile on return on equity, where 100 is best.

Cryo-Cell International is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $32.17M.

StockMap tracks Cryo-Cell International as the 69th largest of the 72 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 48 Neutral, 23 Moderate Underperform and 1 Moderate Outperform.

On that composite Cryo-Cell International ranks 47th of 72 in the group, against a group median of -0.13.